ClinicalTrials.gg
Active, not recruitingNCT07260136Updated Dec 3, 2025

Cervical Spine Abnormalities in Down Syndrome

An observational study in Down Syndrome and Cervical Spine Instability in Down Syndrome, sponsored by Sohag University. Active, not recruiting at 1 site in Egypt. Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2025-12-03.

Sponsored by Sohag University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
2 Years to 18 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Down Syndrome with a site in Egypt — 5 open to participants now, 7 under way, none of them phase 3. Down Syndrome · Egypt.

Started
2025
with 5 others
Observational
6 of 21
2 open now
Registered
15th of 21
by date
Lead sponsor
1 of 21
Sohag University

Among the 21 studies in Down Syndrome with a site in Egypt, this one is one of 6 that started in 2025, is one of 6 observational ones, and was the 15th registered.

Down Syndrome

439 studies on the registry are indexed under Down Syndrome; 99 are open to participants now.

Browse Down Syndrome studies →

Open to participants now

5 of the 21 studies in Down Syndrome with a site in Egypt are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 74 Down Syndrome studies recruiting now, 14 (19%) set no upper age limit and 57 (77%) stop at 75 or younger; 60 take children under 18; 19 take healthy volunteers.

This study: 2 Years to 18 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Down Syndrome with a site in Egypt, or all of them as a file.
02

Study summary

The study aims to determine the prevalence,clinical presentations and radiographic cervical spine abnormalities associated Down syndrome in children at sohag university hospital

03

Conditions studied

  • Down Syndrome
  • Cervical Spine Instability in Down Syndrome

Browse trials for

Keywords

  • Cervical abnormalities associated with Down syndrome
04

Who can participate

Ages eligible
2 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Aims to study the prevalence, clinical presentationsand radiographic cervical spine abnormalities associated with Down syndrome in children at sohag university hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All patients attending to pediatric inpatient and outpatient clinics aged from 2y up to 18 y

Exclusion criteria

Exclusion Criteria:

  • children with other clinical syndromes Children with other neurological disorders (eg. Cerebral palsy , myopathy, neuropathy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Target follow-up
1 Month
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Determine the prevalence, clinical presentations and radiographic cervical spine abnormalities associated with Down syndrome through study completion an average of 1 year .

    Time frame: Asses the perivlance of cervical spine abnormalities in patient with Down syndrome of patients aged from 2 years up to 18 years ,using measure tool atlanoaxial instability in ct neck (ADI>3ml)and other mutliple measures ex(weight,height,eg.)

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Dec 2026, 14 months after the start.

Of 40 non-industry observational studies under Down Syndrome, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's planned 14 months is below that.

Counting every sponsor, half of 55 studies reached it within 34 months; a quarter within 19 and three quarters within 71.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2025
First posted
Dec 3, 2025
StartActual
Oct 23, 2025
Primary completionEst.
Dec 23, 2026
CompletionEst.
Dec 30, 2026
Last update
Dec 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07260136
Lead sponsor
Sohag University
Responsible party
EsraaAMahmoud (Resident physician in pediatric department at sohag university, Sohag University) — Principal investigator
First posted
Dec 3, 2025
Start date
Oct 23, 2025
Primary completion
Dec 23, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Dec 3, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion